Primary Health Properties PLC acquires Assura Plc (2025)

Deal facts

Buyer: Primary Health Properties PLC
Target: Assura Plc
Deal value: Not disclosed
Announced: 12 August 2025
Status: Completed
Sector: Healthcare
Country: United Kingdom
Consideration: cash, shares

Sources

LSE_RNS_Investegate LSE_RNS_Investegate UK_CMA_GOVUK

What we know

Primary Health Properties PLC has agreed to acquire Assura Plc in a strategic acquisition within the healthcare sector. The transaction, announced on 12 August 2025, involves a mixed consideration of cash and shares. Assura Plc is a United Kingdom-based entity operating in the healthcare industry. The deal structure allows for a combination of equity and liquid assets to facilitate the transfer of ownership.

The transaction has reached a completed status as of the latest available information. Regulatory approvals and other standard closing conditions were satisfied to finalise the acquisition. This strategic move consolidates the target's operations under the acquiring group's portfolio. The deal represents a significant development for the UK healthcare landscape. No specific financial value was disclosed in the public announcement regarding the total consideration. The completion marks the end of the negotiation phase for both parties involved.

Weekly digest

Join Exit Mode Insider

Ten deal briefs a week, founder commentary, and the patterns worth paying attention to.

Join Exit Mode Insider, £12/mo

Deal timeline

3 updates

29 Oct 2025CMA Phase 1 clearance
Primary Health Properties plc to acquire Assura plc
{ "title": "PHP / Assura merger inquiry", "parties": [ "PHP", "Assura" ], "opened_date": "2025-07-04", "decision_date": "2025-07-04", "case_state": "closed", "sector": "building-and-construction", "decision_type": "Phase 1 Clearance", "summary_text": "The Competition and Markets Authority (CMA) has investigated the completed acquisition by Primary Health Properties plc of
UK CMA
5 Sept 2025Wholly unconditionalClosed
Primary Health Properties plc to acquire Assura Plc
{ "headline": "Delisting of Assura shares", "issuer": "Assura (AGR)", "announcement_date": "2025-09-05T07:00:00", "category_code": "Other M&A", "body": "FOR IMMEDIATE RELEASE \n\n 5 September 2025 \n\n \n\n Assura Plc (\"Assura\") \n\n Delisting of Assura Shares \n\n \n\n 1. Introduction \n\n On 23 June 2025, the boards of Primary Health Properties plc (\" PHP \") and Assura jointly
LSE RNS
12 Aug 2025Wholly unconditionalClosed
Primary Health Properties PLC to acquire Assura Plc
{ "headline": "Revised Offer Declared Wholly Unconditional", "issuer": "Assura (AGR)", "announcement_date": "2025-08-12T16:10:00", "category_code": "Other M&A", "body": "FOR IMMEDIATE RELEASE \n\n 12 August 2025 \n\n Recommended Combination of \n\n Assura Plc (\"Assura\") \n\n and \n\n Primary Health Properties PLC (\"PHP\") \n\n to be implemented by means of a takeover offer \n\n under
LSE RNS

OpinionExit Mode editorial

We see a clear signal in the completed acquisition of Assura Plc by Primary Health Properties PLC, announced on 12 August 2025. This is a strategic consolidation within the UK healthcare real estate sector, merging two major players in a space defined by long-term lease structures and essential service demand. The deal utilises a mixed consideration structure of cash and shares, a common mechanic in property transactions designed to balance immediate liquidity for sellers with continued alignment through equity participation. For the SME founder watching from the sidelines, this move underscores that scale remains a critical driver of value in regulated property markets where operational efficiency and tenant diversification are paramount.

The regulatory context here is significant given the nature of the assets involved. While the Competition and Markets Authority would typically scrutinise such a merger to ensure it does not stifle competition in local primary care markets, the completion status confirms that clearance was secured. This suggests the combined entity did not breach anti-trust thresholds in a way that would block the transaction. Furthermore, the mixed payment method implies that the buyer is managing its capital structure carefully, likely to preserve cash reserves while offering the target shareholders a stake in the enlarged platform. This is a nuanced approach that balances risk and reward, something that often gets lost in simpler all-cash or all-share deals.

Our view is that this transaction highlights the maturation of the healthcare property sector, where consolidation is becoming the norm rather than the exception. The use of both cash and shares indicates a sophisticated deal structure that requires careful negotiation of change-of-control covenants and potential escrow arrangements to protect both parties. It is a reminder that even in a sector with stable income streams, the mechanics of the exit matter as much as the headline valuation. The successful completion demonstrates that regulatory hurdles can be navigated when the strategic logic is sound and the structure is robust.

For the founder building a business in this space, the lesson is immediate. You must audit your own lease portfolio and tenant mix now to identify any potential competition concerns before you even start talking to buyers. Prepare a clear narrative on how your assets complement rather than compete with potential acquirers, and be ready to discuss how a mixed cash-and-share structure could serve your liquidity and tax planning needs.

Editorial opinion. Not financial or legal advice.

Explore

Browse adjacent archives

Jump from this deal into the sector, buyer, deal type, and year views that carry the strongest contextual signal.

More Healthcare deals More 2025 deals More strategic acquisition deals More from Primary Health Properties PLC All M&A deals

Similar deals

Other Healthcare M&A activity tracked by Exit Mode.

7 May 2026CompletedHealthcare

Shuttle Pharmaceuticals Holdings, Inc. to acquire United Dogecoin Inc.

Shuttle Pharmaceuticals Holdings, Inc. and United Dogecoin Inc. entered the Exit Mode archive.

Buyer: Shuttle Pharmaceuticals Holdings, Inc.
Target: United Dogecoin Inc.
Deal value: Not disclosed
Deal type: strategic acquisition

Read deal Healthcare deals strategic acquisition deals United States deals

29 April 2026CompletedHealthcare

MedPal AI plc to acquire Remedi Solutions Limited

MedPal AI plc and Remedi Solutions Limited entered the Exit Mode archive.

Buyer: MedPal AI plc
Target: Remedi Solutions Limited
Deal value: GBP 310,000
Deal type: strategic acquisition

Read deal Healthcare deals strategic acquisition deals United Kingdom deals

27 April 2026CompletedHealthcare

BIOMARIN PHARMACEUTICAL INC to acquire Amicus

BIOMARIN PHARMACEUTICAL INC and Amicus entered the Exit Mode archive.

Buyer: BIOMARIN PHARMACEUTICAL INC
Target: Amicus
Deal value: Not disclosed
Deal type: strategic acquisition

Read deal Healthcare deals strategic acquisition deals United States deals

22 April 2026CompletedHealthcare

Telomir Pharmaceuticals, Inc. to acquire TELI Pharmaceuticals, Inc.

Telomir Pharmaceuticals, Inc. and TELI Pharmaceuticals, Inc. entered the Exit Mode archive.

Buyer: Telomir Pharmaceuticals, Inc.
Target: TELI Pharmaceuticals, Inc.
Deal value: USD 34,389,710
Deal type: strategic acquisition

Read deal Healthcare deals strategic acquisition deals United States deals

15 April 2026CompletedHealthcare

GSK plc to acquire 35Pharma Inc.

GSK plc has agreed to acquire 35Pharma Inc., a Canadian biopharmaceutical company, for an equity value of USD 950 million. The transaction was structured as a strategic…

Buyer: GSK plc
Target: 35Pharma Inc.
Deal value: USD 950,000,000
Deal type: strategic acquisition

Read deal Healthcare deals strategic acquisition deals Canada deals

Buyer history